Steward Partners Investment Advisory’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-130
Closed -$2.42K 4393
2025
Q2
$2.42K Hold
130
﹤0.01% 3698
2025
Q1
$2.49K Hold
130
﹤0.01% 3595
2024
Q4
$4.68K Buy
+130
New +$4.4K ﹤0.01% 3385
2024
Q2
Sell
-70
Closed -$2.48K 3717
2024
Q1
$2.48K Hold
70
﹤0.01% 3250
2023
Q4
$2.07K Hold
70
﹤0.01% 3195
2023
Q3
$1.45K Buy
+70
New +$1.92K ﹤0.01% 3139
2023
Q1
Sell
-99
Closed -$4.45K 3417
2022
Q4
$4.45K Hold
99
﹤0.01% 2809
2022
Q3
$5K Sell
99
-220
-69% -$12.1K ﹤0.01% 2791
2022
Q2
$19K Sell
319
-1
-0.3% -$82 ﹤0.01% 2257
2022
Q1
$37K Hold
320
﹤0.01% 2078
2021
Q4
$48K Hold
320
﹤0.01% 1937
2021
Q3
$38K Sell
320
-100
-24% -$11K ﹤0.01% 2027
2021
Q2
$41K Sell
420
-300
-42% -$26.8K ﹤0.01% 3738
2021
Q1
$63.5K Buy
720
+500
+227% +$46.5K ﹤0.01% 1860
2020
Q4
$21K Hold
220
﹤0.01% 2047
2020
Q3
$25K Hold
220
﹤0.01% 1812
2020
Q2
$22K Hold
220
﹤0.01% 1741
2020
Q1
$14K Hold
220
﹤0.01% 1740
2019
Q4
$13K Buy
+220
New +$13.6K ﹤0.01% 1928

Other funds holding TNDM

Steward Partners Investment Advisory's TNDM Position: Q3 2025 in Review

Steward Partners Investment Advisory sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 130 shares — an estimated $2.42K sold.

Steward Partners Investment Advisory first reported a position in TNDM in Q4 2019 and held it in 19 quarters. The position peaked at $63.5K in Q1 2021. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Steward Partners Investment Advisory reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 130 Tandem Diabetes Care shares in Q3 2025, an estimated $2.42K.
  • Steward Partners Investment Advisory first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 19 quarters.
  • Steward Partners Investment Advisory's Tandem Diabetes Care position peaked at $63.5K in Q1 2021.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2025, filed 12 Nov 2025.